-
WESTBURY, NY - Aug 7, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it will be hosting a research symposium entitled Innovation in Immuno-oncology: Breaking Down the Barriers on Aug
Aug 7, 2019
-
PRINCETON, NJ - Aug 6, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the launch of BaseCase Data Manager, which allows clients to build interactive, data-driven mobile tools using real-world data sources, such as healthcare claims, costs, quality, outcomes, and population data
Aug 6, 2019
-
WESTBURY, NY - Aug 6, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has acquired Keystone Biologicals, Inc
Aug 6, 2019
-
NUTFIELD, UNITED KINGDOM - Jul 30, 2019 - MR Solutions has received the prestigious Queens Award for Enterprise in recognition of the companys innovative PET imaging technology for use in pre-clinical research
Jul 30, 2019
-
PRINCETON, NJ - Jul 30, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the launch of version 19
Jul 30, 2019
-
ROYAL OAK, MI, UNITED STATES - Jul 25, 2019 - OncoCell MDx, an immunogenomics platform company developing novel, noninvasive molecular diagnostic assays for cancer and other disease, today announced that Marc Stapley has joined the companys Board of Directors
Jul 29, 2019
-
MILWAUKEE, WI - Jul 26, 2019 - Chr. Hansen develops and produces cultures, enzymes, probiotics and natural colors for the food, confectionary, beverages, dietary supplements and animal feed industries
Jul 26, 2019
-
MILWAUKEE, WI - Jul 25, 2019 - Chr. Hansen develops and produces cultures, enzymes, probiotics and natural colors for the food, confectionary, beverages, dietary supplements and animal feed industries
Jul 25, 2019
-
WASHINGTON, DC, UNITED STATES - Jul 24, 2019 -
Washington, DC, July 24, 2019-
How will important reform initiatives, such as the VALID Act, affect the transformation of "diagnostics driven" precision medicine? Regulatory and policy experts will share the latest milestones and projections during the Plenary Keynote Session at the Next Generation Dx Summit, August 20-22, 2019 in Washington, DC
Jul 24, 2019
-
ROYAL OAK, MI, UNITED STATES - Jul 18, 2019 - OncoCell MDx, an immunogenomics platform company specializing in the delivery of novel, noninvasive molecular diagnostic assays, today announced that Kirk Wojno, M
Jul 18, 2019
-
PRINCETON, NJ - Jul 18, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that the entire staff from Compass Strategic Consulting (Compass) has joined Certaras Evidence & Access group
Jul 18, 2019
-
LONDON, UK - Jul 15, 2019 - A fast, accurate and low-cost test for blood potassium levels, which can be used at home and has the potential to improve the safety, health and lifestyle of tens of millions of people worldwide, is being developed by Kalium Diagnostics
Jul 15, 2019
-
LEICESTER, UNITED KINGDOM - Jul 11, 2019 - A new study conducted by UK researchers has shown the potential for a new blood test to not only diagnose human tuberculosis (TB) but also identify those at most risk of developing the disease, according to findings published in medical journal
Clinical Infectious Diseases
Jul 11, 2019
-
WASHINGTON, DC, UNITED STATES - Jul 10, 2019 - Responding to the growth of the global point-of-care (POC) diagnostics market, which is projected to exceed $38 billion by 2022 (MarketsandMarkets), Cambridge Healthtech Institute will expand opportunities to explore POC innovations during its eleventh annual Next Generation Dx Summit, taking place August 20-22, 2019 in Washington, DC
Jul 10, 2019
-
PRINCETON, NJ - Jul 9, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that it has formed a new practice area called Certara Global Health (CGH) to focus its technological expertise on helping to achieve equity in health for all people worldwide
Jul 9, 2019
-
ROYAL OAK, MI, UNITED STATES - Jul 9, 2019 - OncoCell MDxä, an immunogenomics platform company specializing in the delivery of novel, noninvasive molecular diagnostic assays, today announced the appointment of Christopher Thibodeau as its Chief Operating Officer
Jul 9, 2019
-
SAN DIEGO, CA - Jun 28, 2019 - San Diego, CA . . . .
BINDING SITE's
IMMUNOLOGICALS GROUP
is pleased to announce the addition of a new, purified monoclonal antibody to be used for the analysis and testing of the Rubella
Jun 28, 2019
-
PRINCETON, NJ - Jun 25, 2019 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, and Monash University today announced the recipients of the inaugural Certara-Monash University Industry Drug Development Fellowships – Dr
Jun 25, 2019
-
CAMBRIDGE, MA - Jun 19, 2019 - Shimmer Research, a global leader in wearable technology for research applications, and ClearSky Medical Diagnostics, a leader in analyzing wearable data for medical applications, today announced they are partnering to bring a new level of analytic capabilities to the use of wearable sensors in clinical research
Jun 19, 2019
-
KIRKLAND, WA, UNITED STATES - Jun 19, 2019 - Resolution Bioscience, Inc., today announced that its Resolution HRD liquid biopsy assay is being developed as a companion diagnostic for niraparib, a PARP inhibitor that is currently being investigated for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) as part of a research collaboration with Janssen Research & Development, LLC (Janssen)
Jun 19, 2019